Publications by authors named "David Rewolinski"

Claim this Profile
D
Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressure.
Qinhua Huang, Eugene Y Rui, Morena Cobbs, Dac M Dinh, Hovhannes J Gukasyan, David A Rewolinski

J Med Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization.
Edwin Lee, David Rewolinski

Invest Ophthalmol Vis Sci· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design, synthesis, and biological evaluation.
William Vernier, Wesley Chong, David Rewolinski, Samantha Greasley, Thomas Pauly

Bioorg Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Dana D Hu-Lowe, Helen Y Zou, Maren L Grazzini, Max E Hallin, Grant R Wickman, David A Rewolinski

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis